Press Releases

Lexicon Pharmaceuticals Announces Publication of New Xermelo® (Telotristat Ethyl) Data in Clinical Therapeutics	May 04, 2018
Lexicon Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides a Business Update	May 03, 2018
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference	May 01, 2018
Lexicon Pharmaceuticals to Host First Quarter 2018 Financial Results Conference Call and Webcast on May 3, 2018	Apr 26, 2018
Lexicon Pharmaceuticals to Highlight Pipeline Progress at R&D Day on April 10, 2018	Apr 03, 2018
Lexicon Pharmaceuticals Announces EMA Acceptance of Marketing Authorization Application (MAA) for Sotagliflozin to Treat Adults with Type 1 Diabetes	Mar 29, 2018
Lexicon Pharmaceuticals Announces Regulatory Submissions for Sotagliflozin to Treat Adults with Type 1 Diabetes	Mar 26, 2018
Lexicon Pharmaceuticals Announces Poster Presentation at the 15th Annual ENETS Conference	Feb 28, 2018
Lexicon Pharmaceuticals to Present at Upcoming Investor Conferences	Feb 27, 2018
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-year 2017 Financial Results and Provides a Business Update	Feb 22, 2018